According to the strategic cooperation agreement signed by the People's Government of Henan Province and China Pharmaceutical Group, the largest medical and health industry group in China, China Pharmaceutical Group Sinopharm Holdings Co., Ltd. invested 300 million yuan to jointly establish two major companies with Pingdingshan Pusheng Pharmaceutical Co., Ltd.: Sinopharm Holdings Pingdingshan Co., Ltd., which focuses on wholesale business, and Henan Guo Da Pharmacy Chain Co., Ltd., which focuses on retail business. On April 29th, 20 1 1, these two companies will be formally established. This means that the pharmaceutical logistics and retail industries in Yingcheng are facing reshuffle.
China Pharmaceutical Group is the largest pharmaceutical and health industry group in China, which integrates scientific research, manufacturing, logistics and distribution under the direct management of the State Council State-owned Assets Supervision and Administration Commission. With a number of wholly-owned or holding subsidiaries, domestic first-class pharmaceutical, vaccine and blood products manufacturers, high-level scientific research institutes, medicinal materials planting bases and marketing networks all over the country, it undertakes the centralized storage, allocation and supply of national emergency drugs, biotechnology products, Chinese herbal medicines and medical devices, and its scale and strength are second to none in China.
On February 2, 2009, Sinopharm Holdings Nanyang Co., Ltd. was registered in Nanyang Administration for Industry and Commerce. The legal representative is Zhao Ying, whose business scope includes Chinese patent medicines, Chinese herbal medicines, Chinese herbal pieces, chemical pharmaceutical preparations, antibiotics, etc.